Wells Fargo & Company Elevance Health, Inc. Transaction History

Wells Fargo & Company

$429 Billion
Q1 2025

A detailed history of Wells Fargo & Company transactions in Elevance Health, Inc. stock. As of the latest transaction made, Wells Fargo & Company holds 342,729 shares of ELV stock, worth $101 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares

342,729

Previous 314,045 9.13%

Holding current value

$101 Million

Previous $116 Million 28.49%

% of portfolio

0.03%

Previous 0.03%

21 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 13, 2025	BUY	$365.9 - $436.25 $10.5 Million - $12.5 Million	28,684 Added 9.13%	342,729 $149 Million
Q4 2024 Feb 12, 2025	SELL	$365.96 - $514.62 $24.3 Million - $34.1 Million	-66,325 Reduced 17.44%	314,045 $116 Million
Q3 2024 Nov 13, 2024	BUY	$500.12 - $562.29 $5.15 Million - $5.79 Million	10,290 Added 2.78%	380,370 $198 Million
Q2 2024 Aug 13, 2024	BUY	$497.49 - $547.8 $5.13 Million - $5.64 Million	10,303 Added 2.86%	370,080 $201 Million
Q1 2024 May 10, 2024	BUY	$464.61 - $519.96 $7.11 Million - $7.96 Million	15,311 Added 4.44%	359,777 $187 Million
Q4 2023 Feb 09, 2024	BUY	$433.51 - $488.06 $6.4 Million - $7.2 Million	14,762 Added 4.48%	344,466 $162 Million
Q3 2023 Nov 13, 2023	SELL	$414.13 - $475.93 $18.1 Million - $20.8 Million	-43,618 Reduced 11.68%	329,704 $144 Million
Q2 2023 Aug 15, 2023	BUY	$436.33 - $496.2 $3.13 Million - $3.56 Million	7,181 Added 1.96%	373,322 $166 Million
Q1 2023 May 12, 2023	SELL	$446.3 - $502.2 $1.54 Million - $1.73 Million	-3,445 Reduced 0.93%	366,141 $168 Million
Q4 2022 Feb 13, 2023	SELL	$465.23 - $546.77 $3.74 Million - $4.39 Million	-8,035 Reduced 2.13%	369,586 $190 Million
Q3 2022 Nov 14, 2022	BUY	$445.98 - $507.0 $566,840 - $644,397	1,271 Added 0.34%	377,621 $172 Million
Q2 2022 Aug 12, 2022	SELL	$444.32 - $529.84 $33.6 Million - $40 Million	-75,541 Reduced 16.72%	376,350 $182 Million
Q1 2022 May 16, 2022	BUY	$428.44 - $502.48 $6.22 Million - $7.3 Million	14,518 Added 3.32%	451,891 $222 Million
Q4 2021 Feb 14, 2022	SELL	$370.08 - $467.67 $63.5 Million - $80.2 Million	-171,532 Reduced 28.17%	437,373 $203 Million
Q3 2021 Nov 15, 2021	SELL	$357.51 - $398.13 $14.7 Million - $16.3 Million	-41,066 Reduced 6.32%	608,905 $227 Million
Q2 2021 Aug 16, 2021	SELL	$352.19 - $401.9 $22.3 Million - $25.4 Million	-63,299 Reduced 8.87%	649,971 $248 Million
Q1 2021 May 13, 2021	SELL	$287.7 - $371.31 $25.5 Million - $33 Million	-88,759 Reduced 11.07%	713,270 $256 Million
Q4 2020 Feb 09, 2021	BUY	$270.17 - $333.15 $15.2 Million - $18.7 Million	56,217 Added 7.54%	802,029 $258 Million
Q3 2020 Nov 05, 2020	SELL	$245.73 - $284.63 $24.7 Million - $28.6 Million	-100,643 Reduced 11.89%	745,812 $200 Million
Q2 2020 Aug 13, 2020	BUY	$203.3 - $300.59 $7.57 Million - $11.2 Million	37,259 Added 4.6%	846,455 $223 Million
Q1 2020 May 14, 2020	BUY	$174.68 - $307.74 $141 Million - $249 Million	809,196 New	809,196 $184 Million

Others Institutions Holding ELV

# of Institutions

1,853

Shares Held

210M

Call Options Held

1.65M

Put Options Held

1.13M

View Full List

About Elevance Health, Inc.

Ticker ELV
Exchange NYSE
Sector Healthcare
Industry Healthcare Plans
Shares Outstandng 240,000,992
Market Cap $70.7B
Description
Elevance Health Inc. operates as a health benefits company. It supports consumers, families, and communities across the entire care journey connecting to the care, support, and resources to lead healthier lives. It serves approximately 118 million people through a portfolio of medical, digital, pharmacy, behavioral, clinical, and care solutions....

More about ELV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Wells Fargo & Company, based on Form 13F filings with the SEC.

News

Stay updated on Wells Fargo & Company with notifications on news.

Account

Wells Fargo & Company Elevance Health, Inc. Transaction History